Intensive insulin therapy, nevertheless, is essential for clinical management of women with type 1 diabetes (T1D) who are insulin sensitive [54], and for women with T2D who have pronounced insulin resistance [55]. This evidence concerns the gene INS and type 2 diabetes mellitus.